171 related articles for article (PubMed ID: 7678540)
1. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
[TBL] [Abstract][Full Text] [Related]
2. ras gene mutations in human prostate cancer.
Carter BS; Epstein JI; Isaacs WB
Cancer Res; 1990 Nov; 50(21):6830-2. PubMed ID: 2208148
[TBL] [Abstract][Full Text] [Related]
3. Frequent activation of the Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea-induced rat prostate adenocarcinomas and neurogenic sarcomas.
Sukumar S; Armstrong B; Bruyntjes JP; Leav I; Bosland MC
Mol Carcinog; 1991; 4(5):362-8. PubMed ID: 1680340
[TBL] [Abstract][Full Text] [Related]
4. K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men.
Konishi N; Enomoto T; Buzard G; Ohshima M; Ward JM; Rice JM
Cancer; 1992 May; 69(9):2293-9. PubMed ID: 1562975
[TBL] [Abstract][Full Text] [Related]
5. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
6. H-ras oncogene point mutations in arthritic synovium.
Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
[TBL] [Abstract][Full Text] [Related]
7. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
8. Infrequent RAS oncogene mutations in human prostate cancer.
Moul JW; Friedrichs PA; Lance RS; Theune SM; Chang EH
Prostate; 1992; 20(4):327-38. PubMed ID: 1608859
[TBL] [Abstract][Full Text] [Related]
9. K-ras codon 12 and 61 point mutations in bromodeoxyuridine- and N-nitrosomethylurea-induced rat renal mesenchymal tumors.
Calvert RJ; Buzard GS; Anisimov VN; Rice JM
Cancer Lett; 1996 Dec; 109(1-2):1-7. PubMed ID: 9020896
[TBL] [Abstract][Full Text] [Related]
10. K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.
Li S; Rosell R; Urban A; Font A; Ariza A; Armengol P; Abad A; Navas JJ; Monzo M
Lung Cancer; 1994 Jul; 11(1-2):19-27. PubMed ID: 8081702
[TBL] [Abstract][Full Text] [Related]
11. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.
Anwar K; Nakakuki K; Shiraishi T; Naiki H; Yatani R; Inuzuka M
Cancer Res; 1992 Nov; 52(21):5991-6. PubMed ID: 1382850
[TBL] [Abstract][Full Text] [Related]
12. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
13. Lack of evidence of Ki-ras codon 12 mutations in melanocytic lesions.
Albino AP; Nanus DM; Davis ML; McNutt NS
J Cutan Pathol; 1991 Aug; 18(4):273-8. PubMed ID: 1939786
[TBL] [Abstract][Full Text] [Related]
14. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
Namba H; Rubin SA; Fagin JA
Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
[TBL] [Abstract][Full Text] [Related]
15. [Detection of G-T mutations at codon 12 of c-Ha-ras oncogenes in squamous cell carcinomas of the sinus maxillaris].
Liu XF
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(6):345-7, 382. PubMed ID: 1303668
[TBL] [Abstract][Full Text] [Related]
16. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
17. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
[TBL] [Abstract][Full Text] [Related]
19. Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells.
Zhang PL; Calaf G; Russo J
Mol Carcinog; 1994 Jan; 9(1):46-56. PubMed ID: 8297485
[TBL] [Abstract][Full Text] [Related]
20. Analysis of ras DNA sequences in rat renal cell carcinoma.
Recio L; Lane SC; Ginsler J; Walker C
Mol Carcinog; 1991; 4(5):350-3. PubMed ID: 1910479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
